Imaging Brain Metastases of Neuroendocrine Tumors

2020 ◽  
pp. 1083-1093
Author(s):  
Klaas Pieter Koopmans ◽  
A. H. Brouwers
2014 ◽  
pp. 911-920
Author(s):  
Klaas Pieter Koopmans ◽  
Adrienne H. Brouwers

2013 ◽  
Vol 20 (2) ◽  
pp. 159-165 ◽  
Author(s):  
F.M. Brehar ◽  
R.M. Gorgan ◽  
Angela Neacsu

Abstract Neuroendocrine tumors are tumors derived from the cells of the neuroendocrine system. The majority of metastases of neuroendocrine tumors occur in liver, lungs and bone. The brain is an uncommon site of metastasize for this type of tumor. The authors of this paper present a case of brain metastases of neuroendocrine tumor with undetermined primary location. The patient, a 35 yearsold man, was admitted in our clinic with headache, nausea, vomiting and a mild right facial paresis. Head CT scan and cerebral MRI identified two lesions: one larger lesion with mixed solid and cystic components located in the left basal ganglia and thalamus and a second cystic lesion located deep in the right parietal lobe. All complementary investigations (including thoracic CT scan and whole-body MRI) failed to reveal the primary tumor location. Due to the high vital-risks associated with the open surgical procedure, the patient and his family chose the less invasive procedure of stereotactic biopsy. Postoperatively the patient had no additional neurologic deficits, presenting only the initial mild right central facial paresis. The result of immunohistochemistry examination was cerebral metastases of neuroendocrine tumor. The patient was directed to the Institute of Oncology Fundeni for further investigations and therapeutically management. In conclusion, even if these are rare tumors which rarely metastasize in the brain, the neurosurgeons should take in consideration this pathology when they examine a patient with multiple cerebral lesions with unknown location of primary tumor.


2017 ◽  
Vol 5 (1) ◽  
pp. 37-45
Author(s):  
Anussara Prayongrat ◽  
Randa Tao ◽  
Pamela K Allen ◽  
Nandita Guha ◽  
Ganesh Rao ◽  
...  

Abstract Background Stereotactic radiosurgery (SRS) is an established treatment for brain metastases, yet little is known about SRS for neuroendocrine tumors given their unique natural history. Objective To determine outcomes and toxicity from SRS in patients with brain metastases arising from neuroendocrine tumors. Methods Thirty-three patients with brain metastases from neuroendocrine tumors who underwent SRS were retrospectively reviewed. Median age was 61 years and median Karnofsky performance status was 80. Primary sites were lung (87.9%), cervix (6.1%), esophagus (3%), and prostate (3%). Ten patients (30.3%) received upfront SRS, 7 of whom had neuroendocrine tumors other than small cell lung carcinoma. Kaplan-Meier survival and Cox regression analyses were performed to determine prognostic factors for survival. Results With median follow-up after SRS of 5.3 months, local and distant brain recurrence developed in 5 patients (16.7%) and 20 patients (66.7%), respectively. Median overall survival (OS) after SRS was 6.9 months. Patients with progressive disease per Response Assessment in Neuro-Oncology-Brain Metastases (RANO-BM) criteria at 4 to 6 weeks after SRS had shorter median time to developing recurrence at a distant site in the brain and shorter OS than patients without progressive disease: 1.4 months and 3.3 months vs 11.4 months and 12 months, respectively (both P < .001). Toxicity was more likely in lesions of small cell histology than in lesions of other neuroendocrine tumor histology, 15.7% vs 3.3% (P = .021). No cases of grade 3 to 5 necrosis occurred. Conclusions SRS is an effective treatment option for patients with brain metastases from neuroendocrine tumors with excellent local control despite slightly higher toxicity rates than expected. Progressive disease at 4 to 6 weeks after SRS portends a poor prognosis.


2015 ◽  
Vol 17 (suppl 5) ◽  
pp. v52.1-v52 ◽  
Author(s):  
Anussara Songthong ◽  
Randa Tao ◽  
Nandita Guha ◽  
Ganesh Rao ◽  
Pamella Allen ◽  
...  

2015 ◽  
Vol 21 ◽  
pp. 129
Author(s):  
Narjust Duma ◽  
Beatrice Alvarado ◽  
Genevieve Streb ◽  
Andrew Jennis ◽  
Martin Gutierrez

2018 ◽  
Vol 24 ◽  
pp. 110-111
Author(s):  
Franco Grimaldi ◽  
Elda Kara ◽  
Fabio Vanin ◽  
Maria Carpentieri ◽  
Claudia Cipri ◽  
...  

2011 ◽  
Vol 6 (3) ◽  
pp. 44
Author(s):  
SUSAN LONDON

Sign in / Sign up

Export Citation Format

Share Document